Xencor Inc.

09/09/2024 | Press release | Distributed by Public on 09/09/2024 12:42

Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near Term Clinical Plans and Shares Clinical Progress in Early Stage Oncology Programs

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.